Miromatrix Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Revenue	0.95	0.03	0.05	0.25
Revenue Growth (YoY)	2783.54%	-28.94%	-81.39%	-
Cost of Revenue	0.5	0.5	0.5	0.25
Gross Profit	0.45	-0.47	-0.45	0
Selling, General & Admin	8.72	4.64	2.11	2.44
Research & Development	18.3	10.76	7.28	6.27
Other Operating Expenses	3.79	1.1	0.42	0.29
Operating Expenses	30.82	16.5	9.81	8.99
Operating Income	-30.36	-16.96	-10.26	-8.99
Interest Expense / Income	0.05	0.61	0.66	0.05
Other Expense / Income	-0.45	-2.91	-0.61	-4.99
Pretax Income	-29.96	-14.67	-10.31	-4.05
Net Income	-29.96	-14.67	-10.31	-4.05
Shares Outstanding (Basic)	21	11	2	2
Shares Outstanding (Diluted)	21	11	2	2
Shares Change	80.48%	430.44%	5.96%	-
EPS (Basic)	-1.45	-1.28	-4.76	-1.98
EPS (Diluted)	-1.45	-1.28	-4.76	-1.98
Free Cash Flow	-27.75	-18.19	-8.16	-8.43
Free Cash Flow Per Share	-1.34	-1.58	-3.77	-4.12
Gross Margin	47.56%	-1412.13%	-974.58%	-
Operating Margin	-3184.62%	-51306.44%	-22047.17%	-3596.67%
Profit Margin	-3142.21%	-44368.10%	-22156.82%	-1618.72%
Free Cash Flow Margin	-2909.97%	-55018.28%	-17539.04%	-3370.47%
EBITDA	-28.8	-13.89	-9.48	-3.65
EBITDA Margin	-3020.95%	-42003.77%	-20379.65%	-1461.71%
Depreciation & Amortization	1.11	0.17	0.17	0.34
EBIT	-29.91	-14.06	-9.65	-4
EBIT Margin	-3137.20%	-42511.56%	-20745.79%	-1599.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).